- Autoliv showcases future safety solution for urban environments (Stockholm, Sweden, June 11, 2015) – – – Autoliv, Inc. (NYSE: ALV and SSE: ALIVsdb), is showcasing a totally new vacuum braking system – the Torricelli brake – developed for significantly reducing stopping distance for Autonomous Emergency Braking (AEB). Autoliv states the innovation could revolutionize traffic safety in urban environments. Tests have proven the so-called Torricelli brake – a vacuum induced plate below a vehicle which sucks down into the track during emergency braking situation – decreases braking distances with ~40 % in speeds up to 70 kph. The technology, developed at Autoliv’s research plant in Vårgårda, Sweden., is named after 17th century Italian physicist Evangelista Torricelli, known for clinically accounting the vacuum and for inventing the barometer. Many car accidents are caused by late braking with insufficient force. A driver may brake too late for several reasons: He or she is distracted or inattentive; visibility is poor or a pedestrian crosses the street without paying attention. Therefore, several car manufacturers today offer Autonomous Emergency Braking (AEB) systems. Autoliv’s revolutionary Torricelli Brake will radically enhance the efficiency of AEB systems by dramatically reducing the braking distances. Technically, the Torricelli brake is connected to the automatic breaking system, which in turn is rigged to detect hazards ahead. The patented solution uses a 0.3 m2 vacuum plate below the vehicle that activates in merely 0.1 sec and produces a downforce of 15 000 N – independently from the tire-to-track friction. This reduces stopping distances with up to ~40% on wet and dry asphalt, as well as ice surfaces. Autoliv has put a maximum speed limit for activating the system at 70 kph, due to the effectiveness and force of the system. This in turn means that the Torricelli brake will mainly be applicable in urban environments, where for instance inattentive children and cyclists could be avoided. “Even if there are several steps ahead before the Torricelli brake can be put into full-scale production, this is undoubtedly an example of how future innovations can revolutionize traffic safety and save more lives, in particular in urban environments,” says Ola Boström, head of Autoliv Research. “The main hindrance for car manufacturer implementation of the Torricelli brake is simply that it is too efficient. In order to complement existing safety equipment, other safety details such as belt tighteners also need to be updated – due to the major braking force of the Torricelli brake system”, add Ola. “I don´t want to speculate on whether the industry is ready to embrace the Torricelli brake, but so far we have showcased the system for a small number of manufacturers and we have gained substantial interest with this latest innovation. A reason pointing towards a short term, rather than long term, industry adaption is that car manufacturers today increasingly compete and gain market share based on the qualities of their safety systems,” Ola finishes. Inquiries: Thomas Jönsson, Group Vice President Communications. Tel +46 (0)8 58 72 06 27 Ola Boström, Senior Director Autoliv Research. Tel +46 (0)733 61 43 42 About Autoliv Autoliv, Inc., the worldwide leader in automotive safety systems, develops and manufactures automotive safety systems for all major automotive manufacturers in the world. Together with its joint ventures, Autoliv has more than 80 facilities with more than 60,000 employees in 28 countries. In addition, the Company has ten technical centers in nine countries around the world, with 21 test tracks, more than any other automotive safety supplier.Sales in 2014 amounted to US $9.2 billion. The Company's shares are listed on the New York Stock Exchange (NYSE: ALV) and its Swedish Depository Receipts on the OMX Nordic Exchange in Stockholm (ALIV sdb). For more information about Autoliv, please visit our company website at www.autoliv.com. Safe Harbor Statement This report contains statements that are not historical facts but rather forward -looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements include those that address activities, events or developments that Autoliv, Inc. or its management believes or anticipates may occur in the future. All forward-looking statements are based upon our current expectations, various assumptions and data available from third parties. Our expectations and assumptions are expressed in good faith and we believe there is a reasonable basis for them. However, there can be no assurance that such forward-looking statements will materialize or prove to be correct as forward-looking statements are inherently subject to known and unknown risks, uncertainties and other factors which may cause actual future results, performance or achievements to differ materially from the future results, performance or achievements expressed in or implied by such forward-looking statements. Numerous risks, uncertainties and other factors may cause actual results to differ materially from those set out in the forward-looking statements. The Company undertakes no obligation to update publicly or revise any forward-looking statements in light of new information or future events. For any forward-looking statements contained in this or any other document, we claim the protection of the safe harbor for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995, and we assume no obligation to update any such statement.
Torricelli brake reduces stopping distance by up to 40% -
Top 10 Most Recent News Articles
Getlabs Brings GI Test Kits to Your Doorstep
Home Testing: A Game Changer for GI Patients Imagine dragging yourself out of bed, managing gut issues, only to face a grueling trip to a lab. It's the last thing a patient with GI symptoms wants. Enter Getlabs and Genova Diagnostics with a welcome shift: a partnership that promises to bring the lab to your doorstep—literally. The Partnership Expansion Getlabs, the...
Continue Reading
LUNGevity's Bold $1M Bet on Lung Cancer Research
Investing in the Future of Lung Cancer Research Damn, you don't see this kind of commitment every day! LUNGevity Foundation is dropping over a million bucks on the table to swell the ranks of lung cancer researchers. They're not just tossing dollars at established players; they're betting on fresh minds to shake things up in this critical field. Tackling lung cancer isn't...
Continue Reading
Ad Council Expands Board, Taps Meta Exec as Vice Chair
An Unexpected Shuffle at the Ad Council Alright, folks, let's talk shop about the recent shake-up in the nonprofit realm. The Ad Council, which has been around longer than some of the giants controlling today's marketing landscapes, just plumped up its Board of Directors with 23 new heavy-hitters. We're talking about leaders from every nook and cranny of the...
Continue Reading
Radius Global Rebrands to Unite Infrastructure Investments
Changing Gears to Navigate Global Connectivity Alright, buckle up because Radius Global Infrastructure, Inc. is making a move that’ll reshape how they play the digital infrastructure game. As of October 28, 2026, they’ve wrapped APWireless into their fold, waving goodbye to separate identities and hello to a unified brand. If you’ve got a finger in the tech pie,...
Continue Reading
Group 1 Automotive Q3 2026: Profits Soar, Revenues Dip
Profits Up, Revenues Down Here's a tale for the books—Group 1 Automotive reports their third quarter results of 2026 and it's a bit like swapping a thunderstorm for a hurricane. Net income from continuing operations stomped on last year's figures, clocking in at a hefty $102.9 million compared to a skimpy $13.1 million. But don't let that fool you, their total revenues...
Continue Reading
Beta Bionics Faces Securities Fraud Class Action Challenges
The Unexpected Slide of Beta Bionics So your wallet took a bruising with this Beta Bionics deal, eh? It’s another one of those wild tales from the stock jungle where everyone watching the NASDAQ:BBNX action got clipped when reality didn't match the company chest-thumping. Glancy Prongay Wolke & Rotter LLP just laid it out—ripping the Band-Aid off what Beta Bionics...
Continue Reading
Jamaica's Tourism Rebounds Post-Hurricane Challenges
Weathering the Storm: A New Chapter for Jamaica It's been nearly a year since Hurricane Melissa hit, and Jamaica is proving that it won't be pushed around by nature's whims. The island's tourism industry, once battered, is now showing remarkable resilience. With hotels and villas reopening and shaking off the dust, it's safe to say Jamaica is back on its feet, and it's...
Continue Reading
Digimon Card Game Ventures into Digital Realms
A Bold Leap for the Digimon Card Game Folks, if you've been tapping your foot waiting for Digimon to fire up a serious digital game, well, here's your moment. BANDAI CO., LTD. is rolling the dice as they launch pre-registration for DIGIMON ALYSION, a digital twist on the classic card game, across 49 countries. It's not just a game; it's a reimagining. They're not just...
Continue Reading
White House Photographer Reveals Unseen Historic Moments
You don’t just wander into the White House and leave unimpressed, not if you're someone who lived it like David Hume Kennerly. Imagine stepping behind those gates and through history's lens, capturing moments few had the privilege to see. Kennerly's debut as the Chief White House Photographer was at a turning point in America, just after the Nixon saga collapsed in...
Continue Reading
FirstEnergy's New Tech to Bolster Pennsylvania Grid
Electricity Demand Spurs Grid Innovation The winds of change are blowing across Pennsylvania's power grid. FirstEnergy Transmission's (NYSE:FE) subsidiary, Keystone Appalachian Transmission Company (KATCo), is diving into a significant federally funded project to reinforce grid reliability. With electricity demand on an upward trajectory, Pennsylvania and beyond need...
Continue ReadingTop 5 Most Recently Viewed Articles
Discover Why Woori Bank Stands Out as a Dividend Gem
Why Investors Look for Dividend Stocks Plenty of investors chase growth across stocks, bonds, ETFs—you name it. But if you’re focused on income, the goal shifts: you want steady cash coming in from investments you can buy and sell without much friction. That cash can come from interest on bonds, dividends from stocks, and other income-paying assets. A dividend is...
Continue Reading
Lightbeam Health Triumphs Again as KLAS Champion for RPM
Lightbeam Health Solutions Achieves Prestigious Award Lightbeam Health Solutions, recognized nationwide for its leadership in population health enablement technology, has once again demonstrated its commitment to excellence by winning the Best in KLAS award for Remote Patient Monitoring (RPM). This accolade comes with an impressive satisfaction score of 93.6 out of 100...
Continue Reading
Exploring the Best US Online Casinos for Real Money Players
The Rise of Online Casinos: A Gamblers’ Paradise The world of online casinos has undergone a transformation, especially with the recent developments in 2025. Why settle for less when the best real money online casinos are just a click away? These establishments not only offer same-day payouts but have also introduced exciting features that enhance the gaming experience...
Continue Reading
Innovative Investment Fuels Growth in Mental Health Services
Strategic Investment to Transform Mental Health Services Care Solace, a leading provider of mental health care coordination services tailored for K-12 schools and municipalities, has announced a transformative partnership with Lemnis, a philanthropic venture focused on enhancing educational experiences for all learners. This collaboration marks a significant moment for...
Continue Reading
Leading Figures Exit Activist Role in Major Pharmaceutical Firm
Key Management Decisions Impacting Activist Campaign In a significant development, former Pfizer Inc (NYSE: PFE) CEO Ian Read and former CFO Frank D’Amelio have announced their decision to step back from the activist campaign led by Starboard Value. This unexpected move has raised questions about the future direction of the campaign and its impact on Pfizer's corporate...
Continue Reading